Niaviolides, New Macrocyclic Sesquiterpenes
FULL PAPER
˚
CH2), 4.91 (t, J ϭ 7 Hz, 1 H, CH), 5.14 (m, 1 H, CH), 5.67 (m, vated molecular sieves (50 mg, 4 A) and dry dichloromethane
1 H, CH) ppm. 13C NMR: δ ϭ 13.7 (q), 14.4 (q), 17.9 (q), 22.6 (t), (5 mL). The mixture was cooled to Ϫ20 °C, and tert-butyl hydro-
26.1 (t), 39.5 (t), 40.9 (t), 68.5 (t), 118.2 (d), 123.1 (d), 125.6 (d), peroxide solution (0.38 mL, 2.2 mmol, 5.5 anhydrous in nonane)
129.9 (s), 135.4 (s), 159.6 (s), 166.9 (s) ppm. MS (70 eV): m/z (%) ϭ
was added. After the mixture had been stirred for 20 min, (E,E,E)-
39 (25), 41 (24), 67 (23), 82 (100), 83 (14), 93 (27), 107 (33), 121 2 (280 mg, 1.0 mmol) in dry dichloromethane (0.5 mL) was added.
(42). HRMS: calcd. for C15H22O2 234.1620; found 234.1612.
The solution was stirred at Ϫ20 °C for 3 h. Water (0.5 mL) was
then added at 0 °C and the mixture was stirred at room temperature
for 45 min. An NaOH solution (0.8 mL, 30%) saturated with NaCl
was added, and the phases separated. The aqueous phase was ex-
tracted three times with dichloromethane and the combined or-
ganic layers were dried with MgSO4. After removal of the solvent,
the crude product was purified by flash chromatography (pentane/
diethyl ether, 1:1), providing pure epoxyfarnesoate (S,S)-5. Yield:
270 mg (0.96 mmol, 96%). 1H NMR: δ ϭ 1.28 (s, 3 H, CH3),
1.61Ϫ1.73 (m, 2 H, CH2), 1.63 (d, J ϭ 1 Hz, 3 H, CH3), 2.07Ϫ2.21
(m, 6 H), 2.16 (d, J ϭ 1 Hz, 3 H, CH3), 3.01 (t, J ϭ 6 Hz, 1 H,
CH), 3.55 (d, J ϭ 12 Hz, 1 H, CH2), 3.57 (d, J ϭ 12 Hz, 1 H, CH2),
3.69 (s, 3 H, CH3), 5.13Ϫ5.14 (m, 1 H, CH), 5.67 (d, J ϭ 1 Hz,
1 H, CH) ppm. 13C NMR: δ ϭ 14.2 (q), 16.0 (q), 18.8 (q), 25.8 (t),
26.7 (t), 36.2 (t), 40.7 (t), 50.8 (q), 59.7 (d), 60.8 (s), 65.4 (t), 115.3
(d), 123.7 (d), 135.1 (s), 159.8 (s), 167.2 (s) ppm. [α]2D0 ϭ Ϫ11.4 (c ϭ
2.2, diethyl ether). C16H26O4 (282.4): calcd. C 68.06, H 9.28; found
C 67.84, H 9.29.
Mixture of Niaviolide Isomers: The reaction was performed as de-
scribed for (E,E,E)-3, ω-hydroxyfarnesoic acid derived from the
isomeric mixture of farnesol being used as starting material. Yield:
116 mg [0.31 mmol, 31%; mixture of (E,E,E)-3/(Z,Z,E)-3/(Z,E,E)-
3 ϭ 26:33:41].
(2Z,6Z,10E)-Niaviolide [(Z,Z,E)-3]: Compound (Z,Z,E)-3 was ob-
tained as an inseparable mixture with (E,E,E)-3. 1H NMR
(CD2Cl2): δ ϭ 1.62 (s, 3 H, CH3), 1.62 (d, J ϭ 1 Hz, 3 H, CH3),
1.81 (d, J ϭ 1 Hz, 3 H, CH3), 2.00Ϫ2.42 (m, 8 H), 4.42 (s, 2 H,
CH2), 5.04 (t, J ϭ 7 Hz, 1 H, CH), 5.46 (dt, J ϭ 2, J ϭ 7 Hz, 1 H,
CH), 5.51 (d, J ϭ 1 Hz, 1 H, CH) ppm. 13C NMR: δ ϭ 15.4 (q),
23.3 (q), 25.6 (q), 27.2 (t), 28.2 (t), 31.7 (t), 35.1 (t), 67.8 (t), 117.9
(d), 126.2 (d), 129.1 (d), 130.8 (s), 134.2 (s), 156.4 (s), 166.9 (s)
ppm. MS (70 eV): m/z (%) ϭ 39 (49), 41 (49), 53 (33), 54 (29), 55
(24), 67 (46), 68 (32), 77 (27), 79 (37), 80 (32), 81 (24), 82 (100), 83
(22), 91 (33), 93 (68), 94 (26), 105 (28), 107 (51), 111 (40), 121
(95), 135 (60), 166 (21) ppm. HRMS: calcd. for C15H22O2 234.1620;
found 234.1606.
(2E,6E,10S,11S)-10,11-Epoxy-12-hydroxyfarnesoic Acid [(S,S)-6]:
Methyl epoxyfarnesoate [(S,S)-5, 100 mg, 0.36 mmol] was dissolved
(2Z,6E,10E)-Niaviolide [(Z,E,E)-3]: 1H NMR (CD2Cl2): δ ϭ 1.41 in methanol (7 mL), and KOH solution (1 mL, 2 ) was added.
(s, 3 H), 1.52 (s, 3 H), 1.81 (d, J ϭ 1 Hz, 3 H, CH3), 1.90Ϫ2.13 (m, The mixture was stirred at 60 °C overnight and concentrated in
8 H), 4.35 (s, 2 H, CH2), 4.85Ϫ4.92 (m, 1 H, CH), 5.03Ϫ5.06 (m, vacuo, and brine (4 mL) was added to the residue. The mixture was
1 H, CH), 5.69 (s, 1 H, CH) ppm. 13C NMR (CD2Cl2): δ ϭ 14.2 extracted once with diethyl ether, and the aqueous layer was then
(q), 14.2 (q), 22.9 (t), 23.9 (q), 25.6 (t), 31.8 (t), 39.6 (t), 66.5 (t), acidified with HCl (1 ). After extraction with diethyl ether (three
118.0 (d), 123.5 (d), 125.0 (d), 129.1 (s), 130.2 (s), 156.7 (s), 166.6 times) the combined organic phases were dried with MgSO4 and
(s) ppm. MS (70 eV): m/z (%) ϭ 39 (36), 41 (33), 53 (34), 54 (18),
the solvent was evaporated to yield the crude hydroxy acid (S,S)-6
55 (21), 67 (36), 68 (31), 79 (26), 80 (35), 82 (88), 91 (22), 93 (43),
(91 mg, 0.34 mmol, 94%), which was directly used in the next step.
105 (30), 107 (38), 111 (42), 121 (100), 151 (24), 166 (50) ppm. 1H NMR: δ ϭ 1.28 (s, 3 H, CH3), 1.62Ϫ1.72 (m, 2 H), 1.63 (s, 3 H,
HRMS: calcd. for C15H22O2 234.1620; found 234.1603.
CH3), 2.00Ϫ2.29 (m, 6 H), 2.16 (d, J ϭ 1 Hz, 3 H, CH3), 2.91Ϫ3.13
(m, 1 H, CH), 3.57 (d, J ϭ 12 Hz, 1 H, CH2), 3.68 (d, 1 H, CH2),
4.98 (s, 1 H, OH), 4.97Ϫ5.30 (m, 2 H, CH, OH), 5.68 (s, 1 H, CH)
ppm. 13C NMR: δ ϭ 14.1 (q), 19.0 (q), 20.9 (q), 25.7 (t), 26.5 (t),
36.2 (t), 40.9 (t), 60.0 (d), 61.5 (s), 65.3 (t), 115.2 (d), 123.3 (d),
135.1 (s), 162.3 (s), 170.0 (s) ppm.
(2E,6E,10R/S,11R/S)-Epoxyniaviolide [(2E,6E,10R/S,11R/S)-4]: A
solution of (E,E,E)-3 (20 mg, 0.08 mmol) in dichloromethane
(2 mL) was added to a mixture of m-chloroperbenzoic acid (33 mg,
0.1 mmol) in dichloromethane (5 mL) at 0 °C. The reaction was
monitored by TLC. After completion, saturated NaHCO3 solution
(4 mL) was added. The layers were separated and the aqueous one
was extracted three times with dichloromethane. The combined or-
ganic extracts were dried with MgSO4 and the solvent was re-
moved. The crude product was purified by flash chromatography
with pentane/diethyl ether (9:1) as eluent. The minor 6,7-epoxide
could not be isolated. Yield: 16 mg (0.06 mmol, 75%). 1H NMR
(C6D6): δ ϭ 1.11 (s, 3 H, CH3), 1.14Ϫ1.20 (m, 1 H, CH2), 1.32 (s,
3 H, CH3), 1.38Ϫ1.46 (m, 1 H, CH2), 1.77Ϫ1.82 (m, 2 H, CH2),
1.84Ϫ2.17 (m, 4 H), 2.00 (d, J ϭ 1 Hz, 3 H, CH3), 2.86 (dd, J ϭ
2, J ϭ 8 Hz, 1 H, CH), 4.18 (d, J ϭ 12 Hz, 1 H, CH2), 4.29 (d, J ϭ
12 Hz, 1 H, CH2), 4.76 (br. t, J ϭ 3 Hz, 1 H, CH), 5.64 (s, 1 H,
CH) ppm. 13C NMR (C6D6): δ ϭ 14.6 (q), 14.8 (q), 17.5 (q), 24.7
(t), 25.8 (t), 38.1 (t), 40.2 (t), 57.5 (d), 65.0 (t), 118.8 (d), 126.3 (d),
167.1 (s) ppm. MS (70 eV): m/z (%) ϭ 39 (27), 41 (28), 43 (23), 55
(29), 67 (20), 81 (27), 82 (100), 93 (35). HRMS: calcd. for C15H22O3
250.1569; found 250.1585. MS data for the 6,7-epoxide III (70 eV):
m/z (%) ϭ 39 (34), 41 (41), 43 (32), 53 (23), 55 (29), 67 (27), 69
(24), 77 (16), 79 (24), 81 (37), 82 (100), 91 (21), 93 (27), 105 (21),
107 (21), 109 (20), 121 (20), 133 (22), 147 (28).
(؉)-(2E,6E,10S,11S)-Epoxyniaviolide [(S,S)-4]: The preparation
was performed analogously to that of (E,E,E)-1, starting from
(S,S)-epoxyhydroxyfarnesoic acid [(S,S)-6]. Yield: 35 mg
(0.15 mmol, 25%). For NMR and MS data see (2E,6E,10R/S,11R/
S-4). HRMS: calcd. for C15H22O3 250.1569; found 250.1579. The
ee values were determined by GC on a chiral hydrodex-6-TBDMS
phase, operated isothermally at 125 °C; Tr(S,S) ϭ 86.89 min,
Tr(R,R) ϭ 86.65 min. ee ϭ 91%. [α]2D0 ϭ ϩ3.0 (c ϭ 1, diethyl ether).
Acknowledgments
Financial support by the Deutsche Forschungsgemeinschaft and
the Fonds der chemischen Industrie is gratefully acknowledged, as
well as the Kenyan research permit to M. B. We thank Prof. W.
Francke for many helpful discussions in the early stage of the pro-
ject.
[1]
P. R. Ackery, R. I. Vane-Wright, Milkweed butterflies: Their
cladistics and biology, Cornell University Press, New York,
(؊)-Methyl
(2E,6E,10S,11S)-10,11-Epoxy-12-hydroxyfarnesoate
1984.
[2]
[(S,S)-5]: ()-(ϩ)-Diisopropyl tartrate (19 mg, 0.08 mmol) and
Ti(OiPr)4 (16 µL, 0.05 mmol) were added at 0 °C to powdered acti-
´
M. Boppre, R. I. Vane-Wright, Zool. J. Linn. Soc. 1989, 97,
101Ϫ133.
Eur. J. Org. Chem. 2003, 1337Ϫ1342
1341